IC
IBRX icon

IEQ Capital’s ImmunityBio IBRX Stock Holding History

IEQ Capital’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$193K Buy
25,100
+15,100
+151% +$103K ﹤0.01% 1708
2025
Q4 		$19.8K Sell
10,000
-11,476
-53% -$26K ﹤0.01% 1827
2025
Q3 		$52.8K Sell
21,476
-8,305
-28% -$21.4K ﹤0.01% 1796
2025
Q2 		$78.6K Buy
+29,781
New +$80.1K ﹤0.01% 1740

Other funds holding IBRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

IEQ Capital's IBRX Position: Q1 2026 in Review

IEQ Capital increased its ImmunityBio (IBRX) stake by 151% in Q1 2026, buying an estimated $103K and bringing the position to 25,100 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #1708.

IEQ Capital first reported a position in IBRX in Q2 2025 and has held it in 4 quarters since. 386 funds tracked by Wall St. Rank hold IBRX as of Q1 2026.

  • IEQ Capital held 25,100 shares of ImmunityBio worth $193K as of Q1 2026.
  • IEQ Capital bought 15,100 ImmunityBio shares in Q1 2026, an estimated $103K.
  • ImmunityBio made up ﹤0.01% of IEQ Capital's portfolio in Q1 2026, its #1708 holding.
  • IEQ Capital first reported a position in ImmunityBio in Q2 2025 and has held it in 4 quarters since.
  • 386 funds tracked by Wall St. Rank held ImmunityBio as of Q1 2026.

Based on IEQ Capital's 13F filing for Q1 2026, filed 15 May 2026.